Further studies will be required to explore the potential link between SPRY2 and these genes in the context of obesity and T2DM, and in particular, the potential role of SPRY2 in the pathogenesis of liver diseases, such as NAFLD. Here, SPRY2 is linked to obesity due to melanocortin 4 receptor deficiency.